Please assess the completion status of the following clinical trial:

Trial Title: Performance Study of SONA Saliva C-19 Rapid Test

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Up to 500 subjects will be screened, consented, and enrolled to obtain a minimum of 50 eligible candidates. In order to be eligible to participate in this study, an individual must meet all of the following criteria:~1. Presenting to the Emergency Department at HRH.~2. Receiving a COVID-19 RT-PCR test as per standard pathway of care.~3. Provide written informed consent.~4. Patients must be presenting or have experienced at least one (1) or more signs or symptoms of COVID-19 within ≤ 7 days:~   1. Fever as self-described or measured ≥ 38 °C (100.4°F)~  2. Chills~  3. Cough~  4. Shortness of breath~  5. Congestion or runny nose~  6. Difficulty Breathing~  7. Muscle or Body Aches~  8. Vomiting~  9. Diarrhea~  10. New loss of sense of taste or smell~  11. Headache~  12. General malaise~  13. Sore Throat~Exclusion Criteria:~1. Asymptomatic patients.~2. Patients unable to provide a saliva sample.~3. Patients unable to give consent.~4. Patients who will not be receiving a nasopharyngeal RT-PCR test.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SARS_CoV_2 Antigen Rapid Test (Type: EXPERIMENTAL): The same group of patients participated in two arms of the study:~One arm was for obtaining performance data of the Sona Saliva C-19 Rapid test and the comparator arm was to obtain data from the primary care route using approved RT-PCR testing.

Based on this trial design, predict the completion outcome and termination type (if applicable).